Cargando…
A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome
Critically ill patients that survive sepsis can develop a Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS), which often leads to extended recovery periods and multiple complications. Here, we utilized a cecal ligation and puncture (CLP) method in mice with the goal of creat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578131/ https://www.ncbi.nlm.nih.gov/pubmed/28796194 http://dx.doi.org/10.3390/ijms18081741 |
_version_ | 1783260476480684032 |
---|---|
author | Pugh, Amanda M. Auteri, Nicholas J. Goetzman, Holly S. Caldwell, Charles C. Nomellini, Vanessa |
author_facet | Pugh, Amanda M. Auteri, Nicholas J. Goetzman, Holly S. Caldwell, Charles C. Nomellini, Vanessa |
author_sort | Pugh, Amanda M. |
collection | PubMed |
description | Critically ill patients that survive sepsis can develop a Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS), which often leads to extended recovery periods and multiple complications. Here, we utilized a cecal ligation and puncture (CLP) method in mice with the goal of creating a model that concurrently displays all the characteristics of PICS. We observed that, after eight days, mice that survive the CLP develop persistent inflammation with significant myelopoiesis in the bone marrow and spleen. These mice also demonstrate ongoing immune suppression, as evidenced by the decreased total and naïve splenic CD4 and CD8 T cells with a concomitant increase in immature myeloid cells. The mice further display significant weight loss and decreased muscle mass, indicating a state of ongoing catabolism. When PICS mice are challenged with intranasal Pseudomonas aeruginosa, mortality is significantly elevated compared to sham mice. This mortality difference is associated with increased bacterial loads in the lung, as well as impaired neutrophil migration and neutrophil dysfunction in the PICS mice. Altogether, we have created a sepsis model that concurrently exhibits PICS characteristics. We postulate that this will help determine the mechanisms underlying PICS and identify potential therapeutic targets to improve outcomes for this patient population. |
format | Online Article Text |
id | pubmed-5578131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-55781312017-09-05 A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome Pugh, Amanda M. Auteri, Nicholas J. Goetzman, Holly S. Caldwell, Charles C. Nomellini, Vanessa Int J Mol Sci Article Critically ill patients that survive sepsis can develop a Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS), which often leads to extended recovery periods and multiple complications. Here, we utilized a cecal ligation and puncture (CLP) method in mice with the goal of creating a model that concurrently displays all the characteristics of PICS. We observed that, after eight days, mice that survive the CLP develop persistent inflammation with significant myelopoiesis in the bone marrow and spleen. These mice also demonstrate ongoing immune suppression, as evidenced by the decreased total and naïve splenic CD4 and CD8 T cells with a concomitant increase in immature myeloid cells. The mice further display significant weight loss and decreased muscle mass, indicating a state of ongoing catabolism. When PICS mice are challenged with intranasal Pseudomonas aeruginosa, mortality is significantly elevated compared to sham mice. This mortality difference is associated with increased bacterial loads in the lung, as well as impaired neutrophil migration and neutrophil dysfunction in the PICS mice. Altogether, we have created a sepsis model that concurrently exhibits PICS characteristics. We postulate that this will help determine the mechanisms underlying PICS and identify potential therapeutic targets to improve outcomes for this patient population. MDPI 2017-08-10 /pmc/articles/PMC5578131/ /pubmed/28796194 http://dx.doi.org/10.3390/ijms18081741 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pugh, Amanda M. Auteri, Nicholas J. Goetzman, Holly S. Caldwell, Charles C. Nomellini, Vanessa A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome |
title | A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome |
title_full | A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome |
title_fullStr | A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome |
title_full_unstemmed | A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome |
title_short | A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome |
title_sort | murine model of persistent inflammation, immune suppression, and catabolism syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578131/ https://www.ncbi.nlm.nih.gov/pubmed/28796194 http://dx.doi.org/10.3390/ijms18081741 |
work_keys_str_mv | AT pughamandam amurinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT auterinicholasj amurinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT goetzmanhollys amurinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT caldwellcharlesc amurinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT nomellinivanessa amurinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT pughamandam murinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT auterinicholasj murinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT goetzmanhollys murinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT caldwellcharlesc murinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome AT nomellinivanessa murinemodelofpersistentinflammationimmunesuppressionandcatabolismsyndrome |